Abdullah Mohammad Khan

19PUBLICATIONS
29CO-AUTHORS
Economic models and forecastingTraditional, complementary and integrative medicine not elsewhere classifiedGene and molecular therapyPredictive and prognostic markersMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jul 27, 2026
The ClinicalTrials.gov Landscape of Multiple Myeloma Clinical Trials: A 20-Year Analysis of Geographic Distribution and Growth Patterns: USMIRC Analysis.

|Jun 26, 2026
Moving Mountains: Improving Access to Autologous Stem Cell Transplant for Vulnerable Patient Populations.

|Jun 25, 2026
Evaluation of Real-World Studies on Management of Relapsed Multiple Myeloma After BCMA-Directed Therapy Failure from U.S. Academic Centers and USMIRC.

|May 27, 2026
From episodic assessment to comprehensive assessment: integrating real-world monitoring in relapsed/refractory multiple myeloma.

|Mar 14, 2026
A Real-World Analysis of the Safety and Efficacy of Teclistamab for Patients with Relapsed/Refractory Multiple Myeloma and Baseline Renal Impairment-USMIRC Group.

Maha Hameed, Alma Habib, Abdullah Mohammad Khan

|Feb 26, 2026
BCMA-Directed CAR T-Cell Therapy in Patients with Relapsed/Refractory Multiple Myeloma and Renal Impairment.

Alma Habib, Nausheen Ahmed, Abdullah Mohammad Khan

Pageof 4

Frequent Collaborators

6 joint publications

Nidhi Sharma

6 joint publications

Zahra Mahmoudjafari

6 joint publications

Shebli Atrash

5 joint publications

Srinivas Devarakonda